Think carefully...What I see a lot of right now on this forum is a number of people who are tuning their arguments and prognostications to the market's behaviour instead of thinking about the RVX story. The RVX story as it stands at this moment is immutable. No market behaviour can change it. And the philosophical stuff - great reading, a balm to the market weary, of little value. Laziness. Think about the facts - put them in order - draw the conclusions.
As far as the parallel approach to selling RVX and moving towards Phase I, what would the Toronto analysts have RVX do, shut down its research until a buyer appears? That's lazy thinking in the extreme. To draw a negative conclusion from that is your business but act on it at your own peril.
What we do with our RVX shares and the market while we wait for a buyout is our own choice. I've locked in a three-bagger overall and the rest rides. Anybody else in my position would and should do the same. But I have to make the decision every day about the rest of it.
I'm holding it. RVX will be bought out. Pfizer set the price of $1.3 billion for a drug that couldn't reach market and one or two small molecule candidates. Despite Pfizer's recent cutbacks, the Esperion team is still working on it all.
Pfizer set the price. Pfizer is keeping it alive. Apo-A1 is the way of the future and RVX has it.